RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS TO TREAT SARCOPENIA

被引:0
|
作者
Reginster, J. -Y. [1 ]
Cooper, C. [2 ]
Rizzoli, R. [3 ]
Kanis, J. A. [4 ]
Appelboom, G. [5 ]
Bautmans, I. [6 ]
Bischoff-Ferrari, H. A. [7 ]
Boers, M. [8 ]
Brandi, M. L. [9 ]
Bruyere, O.
Cherubini, A. [10 ]
Flamion, B. [11 ]
Fielding, R. [12 ]
Van Loon, L. [13 ]
McCloskey, E. V. [14 ]
Mitlak, B. [15 ]
Pilotto, A. [16 ]
Reiter-Niesert, S. [17 ]
Rolland, Y. [18 ]
Tsouderos, Y. [19 ]
Visser, M. [20 ,21 ]
Cruz-Jentoft, A. J. [22 ]
机构
[1] Univ Liege, Dept Publ Hlth & Hlth Econ, Liege, Belgium
[2] Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton SO9 4XY, Hants, England
[3] Univ Hosp Geneva, Geneva, Switzerland
[4] Univ Sheffield, Sch Med, Sheffield, S Yorkshire, England
[5] Columbia Univ, Dept Neurol Surg, Med Ctr, New York, NY USA
[6] Vrije Univ Brussel, Frailty Ageing Res Dept, Brussels, Belgium
[7] Univ Zurich Hosp, Geriatr & Aging Res, CH-8091 Zurich, Switzerland
[8] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands
[9] Univ Florence, Florence, Italy
[10] INRCA Ancona, Dept Gcriatry, Ancona, Italy
[11] Univ Namur, Namur, Belgium
[12] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Nutr Exercise Physiol & Sarcopenia Lab, Boston, MA USA
[13] Maastricht Univ, Dept Human Movement Sci, Med Ctr, NL-6200 MD Maastricht, Netherlands
[14] Univ Sheffield, Sheffield, S Yorkshire, England
[15] Eli Lilly & Co, Indianapolis, IN 46285 USA
[16] Azienda ULSS 16 Padova, Geriatr Unit, Padua, Italy
[17] Fed Inst Drugs & Med Devices BfArM, Bonn, Germany
[18] CHU Toulouse, Clin Gerontol, Toulouse, France
[19] Inst Rech Int Servier, Suresnes, France
[20] Vrije Univ Amsterdam, Amsterdam, Netherlands
[21] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[22] Univ Hosp Ramon & Cajal, Dept Geriatry, Madrid, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SE11
引用
收藏
页码:S62 / S62
页数:1
相关论文
共 50 条
  • [1] Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
    Jean-Yves Reginster
    Cyrus Cooper
    René Rizzoli
    John A. Kanis
    Geoff Appelboom
    Ivan Bautmans
    Heike A. Bischoff-Ferrari
    Maarten Boers
    Maria Luisa Brandi
    Olivier Bruyère
    Antonio Cherubini
    Bruno Flamion
    Roger A. Fielding
    Andrea Ildiko Gasparik
    Luc Van Loon
    Eugene McCloskey
    Bruce H. Mitlak
    Alberto Pilotto
    Suzanne Reiter-Niesert
    Yves Rolland
    Yannis Tsouderos
    Marjolein Visser
    Alfonso J. Cruz-Jentoft
    [J]. Aging Clinical and Experimental Research, 2016, 28 : 47 - 58
  • [2] Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
    Reginster, Jean-Yves
    Cooper, Cyrus
    Rizzoli, Rene
    Kanis, John A.
    Appelboom, Geoff
    Bautmans, Ivan
    Bischoff-Ferrari, Heike A.
    Boers, Maarten
    Brandi, Maria Luisa
    Bruyere, Olivier
    Cherubini, Antonio
    Flamion, Bruno
    Fielding, Roger A.
    Gasparik, Andrea Ildiko
    Van Loon, Luc
    McCloskey, Eugene
    Mitlak, Bruce H.
    Pilotto, Alberto
    Reiter-Niesert, Suzanne
    Rolland, Yves
    Tsouderos, Yannis
    Visser, Marjolein
    Cruz-Jentoft, Alfonso J.
    [J]. AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2016, 28 (01) : 47 - 58
  • [3] Considerations in the Development of Drugs to Treat Sarcopenia
    Brass, Eric P.
    Sietsema, Kathy E.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 (03) : 530 - 535
  • [4] Recommendations for the registration of drugs used in the treatment of osteoarthritis
    Dougados, M
    Devogelaer, JP
    Annefeldt, M
    Avouac, B
    Bouvenot, G
    Cooper, C
    Dieppe, P
    Ethgen, D
    Garattini, S
    Jones, EA
    Kaufman, JM
    Leeming, M
    Lemmel, EM
    Lohmander, S
    Menkes, CJ
    Nuki, G
    Paolozzi, L
    Pujol, JP
    Rovati, L
    Serni, U
    Spector, T
    Tsouderos, Y
    Veys, EM
    Weseloh, G
    Reginster, JY
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (08) : 552 - 557
  • [5] Recommendations for the registration of drugs used in the treatment of rheumatoid arthritis
    Lemmel, EM
    Reid, DM
    Nuki, G
    Avouac, B
    Bardin, T
    Bouvenot, G
    Cauwenberge, H
    Cluzel, M
    Devolgelaer, JP
    Duff, GW
    Emery, P
    Ethgen, D
    Kreutz, G
    Menkes, CJ
    Reidel, H
    Serni, U
    Van der Auwera, P
    Veys, E
    White-Guay, B
    Reginster, JY
    [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1998, 37 (02): : 211 - 215
  • [6] GREES recommendations for the registration of new drugs in the prevention and treatment of osteoporosis
    Reginster, JY
    Compston, J
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1997, 60 (05) : 488 - 488
  • [7] Recommendations for the Registration of Drugs Intended for Use in the Treatment of Male Osteoporosis
    J. M. Kaufman
    J. Compston
    M. A. Audran
    B. Avouac
    J. P. Devogelaer
    E. M. Lemmel
    L. Vanhaelst
    J. Y. Reginster
    [J]. Calcified Tissue International, 1999, 65 : 4 - 7
  • [8] Recommendations for the registration of drugs intended for use in the treatment of male osteoporosis
    Kaufman, JM
    Compston, J
    Audran, MA
    Avouac, B
    Devogelaer, JP
    Lemmel, EM
    Vanhaelst, L
    Reginster, JY
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1999, 65 (01) : 4 - 7
  • [9] GREES Recommendations for the Registration of New Drugs in the Prevention and Treatment of Osteoporosis
    J. -Y. Reginster
    J. Compston
    [J]. Calcified Tissue International, 1997, 60 : 488 - 488
  • [10] The GREES recommendations for the registration of new drugs in the prevention and treatment of osteoporosis
    Kanis, JA
    Delmas, P
    Meunier, P
    Johnston, C
    Bonjour, JP
    Christiansen, C
    Lindsay, R
    Bone, H
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1996, 59 (05) : 410 - 411